To evaluate the mechanism of the promoting effect of goitrogens on thyroid tumorigenesis, well-known goitrogens having different pharmacologic action, i.e., thiourea, phenobarbital sodium (PB), potassium thiocyanate (KSCN), and 3,4,5,6-tetrachloro-2',4',5',7'-tetraiodo-fluorescein sodium salt (Rose Bengal B, FD&C Red No. 105) (FRIOS) were administered to the DHPN-initiated and non-initiated F344 male rats in the drinking water for 25 weeks. Remington's iodine deficient diet (I-del) was fed as a positive control. These goitrogens showed significant tumor promoting erect or promoting tendency on the rat thyroids. According to the changes in thyroid morphology and thyroid-related hormone titers observed in the present study, we proposed to classify goitrogens at least intq 2 groups, i.e., iodine deficiency-type promoters and the iodine excess-type promoters. The former contains goitrogens inducing TSH-stimulated diffuse goiter composed of uniform follicles with activated tall follicular epithelial cells, such as thiourea, KSCN and PB, and the latter contains goitrogens inducing colloid goiter composed of a mixture of colloid-rich follicles with flat follicular cells and normal-looking follicles with cuboidal follicular cells, such as FRIOS. This classification may be useful for the risk assessment of goitrogens.
INTRODUCTION
Long-term exposure to the thyroid stimulating hormone (TSH) by transplantation of TSH-secreting pituitary gland tumor produced thyroid gland hyperplasia composed of tall follicular epithelium with reduced amount of colloid and thyroid tumors in rodents (1 7). Most of the classic and potent goitrogens including thiourea, sulfonamides and iodine deficient diet are also known to produce thyroid hyperplasia and thyroid tumor, and are regarded to affect thyroids by increased serum level of TSH, which is secreted from the pituitary as a consequence of reduction in serum level of thyroid hormones by the effect ofgoitrogens (13, 26) . Recently, iodinated fluorescein-derived food dyes, 2,4,5,7-tetraiodo-fluorescein disodium salt (erythrosine or FD&C Red No. 3) (FR3) and 3,4,5,6-tetrachloro-2',4',5',7'-tetraiodo-fluorescein sodium salt (Rose Bengal B or FD&C Red No. 105) (FR105) were rgpd'ited,to induce thyroid tumors in rodents when given orally (21,'22, 35) . It was reported that the FR3 interfered with the peripheral deiodination of T4 to T3 and increased the secretion of the TSH from the pituitary (35) . However, some investigators reported that the goiters induced by both FR3 and FR105 were morphologically quite different from those induced by the TSH-increasing goitrogens (2 1,22) . We, therefore, compared the effect of 
MATERIALS AND METHODS

Aiiirttals
Six-week-old specific-pathogen-free F344/DuCrj male rats (Charles River Japan Inc., Kanagawa, Japan) were housed 4 or 5 to a plastic cage and kept in an air-conditioned room (bamer system) at a temperature of 24 f 1°C and a relative humidity of 55 k 5%.
Experinletit
Three hundred sixty rats were divided into 12 groups of 30 rats. A single dose of 280 mg DHPN (Nakarai Chemicals Ltd., Kyoto) per 100 g body weight was injected subcutaneously to rats in Groups 1 through 6. Rats in Groups 7 through 12 received saline. As shown in Table I , 0.25% thiourea (Nakarai Chemicals Ltd., Kyoto) (Groups 2 and 8), 0.05% PB (Wako Pure Chemicals Ltd., Osaka) (Groups 3 and 9), 0.5% KSCN (Nakarai Chemicals Ltd., Kyoto) (Groups 4 and lo), and 0.5% FR105 (Benifuji Chemicals Ltd., Tokyo) (Groups 5 and 1 1) were administered in the drinking water ad libitiinz from week 2 to 26. In Groups 1 and 7,-Remington's iodine deficient diet No. 347 (I-def) (29) prepaced by Oriental Yeast Co. Ltd., Tokyo was fed for 25 weeks. The I-def diet contained 16 k 2 ng/g iodide (measured by neutron activation analysis at Japan Chemical Analysis Center, Chiba). Other groups were fed with basal diet (CRF-I, Oriental Yeast Co. Ltd., Tokyo) containing sufficient amount of iodine, i.e., 0.8 f 0.17 pg/g. On week 26, all the rats were anesthetized, aortic blood was sampled and sacrificed. Thyroids and related organs were fixed with buffered formalin, sections were routinely stained with hematoxylin and eosin and observed micro-scopically for the development of thyroid lesions. In addition, percent area of follicular epithelial cell to total thyroid area was measured as a quantitative index of the thyroid hypcrplasia by a TAS-plus image analyzer (Leitz Wetzlar, West Germany). Left lobe of the thyroid of 3 rats from each group were fixed in glutaraldehyde and osmic acid, embedded in epoxyresin, sectioned, double-stained with uranyl acetate and lead citrate, and observed with a JEOL CX-120 electron microscope.
Hormone Assay
Serum T4, T3, and rT3 were measured by Enzymun-Tests (Boehringer Mannheim Yamanouchi, Tokyo) and serum TSH was measured by rat TSH kits (NIADDK-anti-rTSH-S-5, NIADDK-rTSH-RP-2 and NIADDK-rTSH-1-6 (chloramine T method)) donated from National Hormone and Pituitary 
Histological Biagtiosis .
Diagnostic criteria of nodular lesions of the follicular cell origin in the rat thyroid differs from time to time and is still controversial. To keep correspondence with human lesions, we referred to the classification of human thyroid tumors (19) to the largest extent. Briefly, in humans, papillary adenoma is not defined and a papillary neoplasm is diagnosed as papillary carcinoma. Cytologic features, such as ground glass appearance, cytoplasmic inclusion and grooving of the nuclei are believed to be specific for this lesion so that follicular variant of papillary carcinoma is diagnosed (6) . Follicular carcinoma is distinguished from follicular adenoma only by the presence ofcapsular invasion or vascular invasion regardless of the cellular atypism. According to the cellular and structural atypism, the lesions diagnosed as carcinoma are divided into well-differentiated carcinomas which show good prognosis; poorly-differentiated ones which show worse prognosis, and anaplastic ones which show the worst prognosis (32).
On the other hand, it is well known that rat thyroid tumors frequently lack a firm capsule and are composed of mixed papillary and follicular types. It is likely that there is no cytologic feature specific for either type. Additionally, most of the invasive counterpart of the tumors are poorly-differentiated component showing trabecular or sheet-like arrangement devoid of colloid. Anaplastic carcinoma is rare. Therefore, we concluded that it is meaningless in rats for the time being to classify carcinomas of follicular cell origin into follicular, papillary or other types, and to distinguish adenomas from noninvasive carcinomas. In this report, we classified rat thyroid nodular lesions into 4 categories as follows: i) adenomatous nodules as lesions comparable to adenomatous goiter nodules or hyperplastic nodules in human; ii) adenomatous goiters as thyroids occupied with multiple adenomatous nodules (more than 4 nodules per lobe); iii) thyroid neoplasms as nodules composed of neoplastic epithelial growth apparently distinguished from and without transition to the surrounding thyroid tissue; and iv) thyroid neoplasm with invasion as thyroid neoplasms accompanied with apparently invasive component to the surrounding thyroid or extrathyroidal tissue. This order entails the progression or advancement of the thyroid lesions. C-cell neoplasm is disregarded in this study (cf. Table I) .
RESULTS
Body weight, thyroid weight and histological lesions of the thyroids in each group are summarized in Table I . The numbers of the thyroid lesions N, AG, and AN represent the number of rats with the most advanced lesions so that the sum N + AG + A N does not exceed the effective number of rats.
("1) simply represents the number of rats having invasive neoplasms.
Thyroid Tionor Yield atid Histology iii DHPN-Initiated Rats
The thyroids of rats in Groups 1 (DHPN + I-def) and 2 (DHPN + thiourea) were markedly enlarged.
Histologically, these thyroids were totally replaced by multicentric neoplasms composed of mixed papillary and follicular patterns with various atypism. Poorly-differentiated components invaded thyroid capsules, vessels and, in some cases, the tracheal wall ( Fig. la) . Lung metastases were observed in 2 cases in Group 2. Rats in Groups 3 to 7 had single or multiple discrete nodules. Histologically, most of them were diagnosed as adenomatous nodules or adenomatous goiters ( Fig. 1 b) although thyroid neoplasms were also found with relatively high incidence in Group 3 (Fig. lc) . Most of the thyroid neoplasms observed in these groups also accompanied poorly-differentiated elements infiltrating into the surrounding thyroid tissue (Fig. Id) . Only one C-cell tumor was found in Group 6 (DHPN + basal diet), although C-cell tumor is one of the most com'mon-spontaneous tumors in this strain of rats (23): 4 
Morphologic Changes of the Thyroids iii Noit-Iiiitiated Rats
Unlike initiated groups, no neoplastic lesion was induced in non-initiated groups (Groups 7 through 12).
The thyroids of rats fed with I-def diet (Group 7) showed marked diffuse hyperplasia. They were homogeneously composed of small follicles with tall TOXICOL~GIC PATHOLOGY follicular epithelial cells and reduced amount of colloid ( Fig. 2a ). The Yo area of follicular cells was 96%.
Electron microscopically, the epithelium was tall and had longer and thicker microvilli than that of the control. Cytoplasmic blebbing against lumen was often found. Lysosomes and phagolysosomes were slightly reduced in number. Rough endoplasmic reticulum (rER) reduced slightly in number and dilated. Mitochondria increased slightly in number and elongated in shape. Polysomes were scanty. Exocytotic vesicles increased slightly in number with rod shaped ones in some epithelium and absent in others (Fig. 2b) . These findings coincide with previous reports by other authors (4,4 1 ). An adenomatous nodule was observed in this group and was morphologically indistinguishable from those induced in DHPN-initiated rats.
The thyroids of rats treated with thiourea (Group 8) showed diffuse hyperplasia very similar to those of I-def rats. The % area of follicular cells was 85%. Electron microscopic features were also similar to those of Group 7 (I-def) except for reduced number of exocytotic vesicles (Fig. 2c ). Five adenomatous nodules which were morphologically indistinguishable from those induced in DHPN-initiated rats were also induced in this group.
The thyroids of rats treated with PB (Group 9) showed slight diffuse hyperplasia uniformly composed of smaller follicles with taller epithelium than those of the control. Electron microscopic features were, though mild in degree, basically similar to those observed in Group 8 (thiourea-treated rats) except for slight increase in lysosomes in number.
The thyroids of KSCN treated rats (Group 10) also showed slight diffuse hyperplasia. The follicular epithelial cells, however, were cuboidal and the amount of colloid increased (Fig. 3a ) so that the % area of follicular cells was smaller than that of the control. Electron microscopically, the height of the epithelial cells were slightly shorter than that of the control. Exocytotic vesicles, lysosomes, rER and mitochondria reduced in number, and phagolysosomes were smaller in size (Fig. 3b, c) .
The thyroids of rats treated with FRlO5 (Group 11) were quite different in morphology from the others. They were composed ofa mixture ofcolloidrich large follicles lined by a layer of flat follicular epithelial cells and normal-sized follicles lined by the cells of normal height (Fig. 4a) . The overall % area of follicular cells of FRlO5-treated rats was the smallest in the present experiment. Electron microscopic features of the epithelium of normal-sized follicles were almost the same with that of the control. However, flat epithelium ofcolloid-rich follicle had atrophic organella with short and scant microvilli (Fig. 4b, c) . 
Honirotral Changes in DIIPN-Initiated atid Noti-Itiitiated Rats
Changes in serum titer of TSH and thyroid hormones in each group are summarized in Table 11 .
Iodine deficient rats (Group 7) showed marked increase in TSH and decrease in T4. In this group, T3 remained unchanged and rT3 decreased. Thioureatreated rats (Group 8) also showed the same pattern of hormonal changes except for T3 which trebled the control. These hormonal changes were accelerated in DHPN-initiated groups (Groups 1 and 2) . KSCN-and PB-treated rats (Groups 9 and 10) showed slight to moderate increase in TSH and T3 and decrease in T4. FR105, on the other hand, raised T4 but didn't alter the titers ofTSH and T3 (Group 1 l), although it raised TSH in the DHPN-initiated group (Group 5).
DISCUSSION
In the present study, all goitrogens including I-def diet were given to rats for 25 weeks. This administration period seems to be long enough to analyze chronic hormonal effects of the goitrogens, according to a report that hormonal changes induced by iodine deficient diet became stable after 12 weeks (30).
Remington's I-def diet in the present study acted as a prefect positive control. It strongly suppressed thyroid hormones, increased TSH, induced typical morphologic changes and promoted tumorigenesis of the thyroid as previously reported by others (1, 3, 9) .
Thiourea, an inhibitor of iodination of thyroglobulin and coupling reaction (l4), is known to produce thyroid tumors in rats (28) . In the present experiment, it affected rats as I-def diet except for high T3. From the changes in the thyroid histology and related hormones, it was apparent that thiourea promoted thyroid tumorigenesis by inducing hypersecretion of TSH from the pituitary. The rise in T3 may be explained by the facts that thiourea does not inhibit deiodination of T4 to T3 (15, 20) , and that peripheral degradation of thyroid hormones is inhjbitgd in hypothyroidism (10) . ' PB has been reported to promote thyroid tumorigenesis by acceleratingT4 clearance in the liver which leads to the hypersecretion of TSH from the pituitary (24). In the present experiment, PB induced morphologic changes compatible with the advocated mechanism in non-initiated rats and significant increase of thyroid tumors in initiated rats, though the rise in serum TSH was not significant. At present, whether PB directly affect thyroid glands or pituitary glands is uncertain. There is a slight possibility of nerve-mediated effect of PB on the thy-Toxico~o~rc PATHOLOGY roid, since PB blocks sympathetic nerves (18) and superior cervical ganglionectomy induces thyroid enlargement in rats (27) . Further investigations are required on this point. KSCN interferes with the thyroid hormone synthesis mainly by raising the iodine exit rate from follicular cells to the blood stream (34, 38) . It is reported that chronic administration of KSCN induced colloid goiter in rats (40) and that KSCN accumulated colloid even when chronically administered with low-iodine diet in mice (36) . In the present experiment, KSCN reduced T4, raised TSH and promoted thyroid tumorigenesis as a TSH-mediated promoter. Different from the other TSH-mediated goitrogens, however, KSCN accumulated colloid in the follicles as reported so that the % area of follicular cells was even smaller than that of the control. Fine structure of the follicular cells indicated that the cells were rather hypofunctional than that of the control. The discrepancy between the rise in serum TSH and the status of the follicular cells in KSCN-treated rats may explain the inconsistency between high TSH and low tumor yield, when compared with the rats treated with PB. The mechanism of colloid accumulation by KSCN remains unknown.
Both FR3 and FR105, iodinated fluorescein dyes, were reported to induce colloid goiters (7, 16, 22) and to promote thyroid tumors in rodents (2 1, 22, 35) . F A O N H O (35) stated that fine structural changes induced by FR3 were compatible with that induced by high TSH and that T3 administration prevented the effect of FR3. F A O N H O (35) also concluded that FR3 inhibited T4-to-T3 deiodination (3 1) which leads to a decrease in serum T3 level and consequent rise in serum TSH, and that only negligible amount of free iodine was released from the compound. However, several investigators have mentioned that the colloid goiters induced by FR3 and FR105 were qualitatively different from those induced by iodine deficiency or other TSH-mediated goitrogens (21, 22) . In the present experiment, goiters induced by FR105 could be morphologically distinguished from those induced by typical TSHmediated goitrogens in two respects; firstly, the goiters in FRlO5-treated. rats were composed of a mixture of clusters of colloid-rich follicles with flat epithelium and normal-loolhng follicles. Ultrastructurally, the flat follicular cells showed completely inactivated morphology. Secondary, the overall Yo area of follicular cells was much smaller than that of the control rats. In addition, hormonal changes in FRlO5-treated rats were also different, i.e., T4 raised and both TSH and T3 remained unchanged.
Literally, an excess amount of iodine induces morphologic and hormonal changes similar to those ' ; 01.
18, NO. 2, 1990 THYROID TU.MOR PROMOTION BY GOITROGEKS FR 105 have bccn rcponed as an estraneous source of iodide both in human and rodents (2, 5, 12, 37) though this was rcnounccd by FAOIWHO (35) . From these facts, it is considered that the effect of the FR 105 on the thyroid may be equivalent to that of the excessive administration of iodine. Thyroid tumor promoters have been almost uniformly regarded to act on thyroid via TSH secreted from the pituitary. This rule has also been applied in the process of risk assessments of thyrotropic compounds on thyroid carcinogenesis. However, from the results obtained here, we propose that thyroid tumor promoters can be classified into 2 groups mainly by their effect on thyroid morphology, i.e., iodine deliciency-type promoters such as thiourea, PB and KSCS which induce TSH-stimulated diffuse goiter composed of uniform follicles with activated la11 follicular cells, and iodine excess-type promoters such as FRl05 which induce colloid goiter composed of a mixture of colloid-rich follicles with flat follicular cells and normal-looking follicles with cuboidal follicular cells. Additionally, the former type may hrther be subclassified into colloid depletiontype (thiourea, PB) and colloid accumulation-type (KSCN). Specifying these types of thyroid promoters should be useful in thc process of risk assessment of goirrogens, because the iodinated compounds such as Amiodarone and Lipiodol are already in human usc and reported to increase protein bound iodine in human and animals, although there have been no systematic cvaluarion ofthem (25, 33) . Further investigation on the promoting mechanism of iodinc excess will be needed.
